Psychedelic nasal spray shows promise for alcohol addiction in small trial
Disease control
Completed
This early-phase study tested a single nasal spray dose of BPL-003, a psychedelic drug, combined with psychological support in 13 adults with moderate to severe alcohol use disorder. The main goals were to check safety and tolerability, and to explore effects on drinking behavior…
Phase: PHASE2 • Sponsor: Beckley Psytech Limited • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC